“Retrospective Evaluation of the Analgesic Effects of Molecular Target Agents Against Cancer Pain and Oxaliplatin-Induced Chronic Peripheral Neuropathy” (2022) Journal of Analytical Oncology, 11, pp. 40–44. doi:10.30683/1927-7229.2022.11.06.